Treatment of Parkinson's disease and related disorders using postpartum derived cells
US7875273B2 · kind B2 · utility
64Cited by
73References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 2005 |
| Grant date | Jan 25, 2011 |
| Priority date | — |
| Expiry date | Jul 22, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/03
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cells derived from postpartum tissue such as the umbilical cord and placenta, pharmaceutical compositions comprising such cells, and methods for using such cells and pharmaceutical compositions to treat patients having a neurodegenerative condition of the substantia nigra or striatum, such as Parkinson's disease, are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.